Based on our results, BRCA2 carriers at the 10th percentile of the ovarian cancer PRS have an estimated 6% lifetime risk and approximately 38% of BRCA2 mutation carriers have a lifetime risk of ovarian cancer that is less than 10%. The gene discussed is BRCA2; the disease is ovarian cancer.